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The relationship between delayed hypersensitivity and antibody formation is not 
yet clear, although the subject has been studied  extensively. While delayed hyper- 
sensitivity and antibody formation could be phases of the same process,  some data 
suggest that these two phenomena may be fundamentally different and mediated by 
separate mechanisms. For example, it has been shown that the acquisition of delayed 
hypersensitivity can be suppressed by the antimetabolite 6-mercaptopurine (6-MP) 
without a  concomitant suppression  of antibody formation (1-3). In agammaglobu- 
linemia humoral antibody synthesis is markedly impaired, while  delayed hypersen- 
sitivity may be expressed normally (4). The reverse is true in Hodgkin's disease:  the 
formation of circulating antibodies is normal, but delayed hypersensitivity reactions 
are profoundly depressed  (5).  There is thus some evidence suggesting  that delayed 
hypersensitivity and antibody formation are not necessarily directly linked together. 
The present experiments were undertaken  in  order  to investigate whether 
delayed hypersensitivity and antibody formation are equally affected by the 
induction of ~mmunologic tolerance. By this approach, it was found that guinea 
pigs could be rendered tolerant  to hapten protein conjugates with respect to 
delayed hypersensitivity  only,  without  concomitant  impairment of antibody 
formation to the same antigen. 
Materials  and Methods 
Animals.--Outbred  newborn guinea pigs and adult  animals weighing 400 to 600  g  were 
used for most of these experiments. Albino guinea pigs weighing 250 to 350 g were used for 
passive cutaneous anaphylaxis. 
Antigens.--2,4-Dinitrophenylsulfonic acid (I)NPS) (Eastman Kodak Co., Rochester, New 
York) twice recrystallized  was used for coupling to 3 different carrier proteins: bovine gamma 
globulin (Armour Pharmaceutical Co., Kankakee, Illinois), crystalline bovine serum albumin 
(Armour), and rabbit gamma globulin (Pentex, Inc.,  Kankakee,  Dlinois). O-Chlorobenzoyl 
chloride (Eastman Kodak) was coupled to bovine gamma globulln.l 
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Conjugates.--DNPS  was conjugated according to the method of Eisen (6), as modified by 
Ovary and Benacerraf (7).  After extensive dialysis against distilled water buffered at  pH  8 
with potassium  carbonate,  the protein concentration  of conjugate was  determined  by  the 
Folin method, and the average number of hapten groups per molecule of protein  conjugate 
was calculated from its optical density, related to the extinction coefficient of dinitrophenyl 
at 360 #. Two series of experiments were conducted, one with preparation I, containing 37 
groups of hapten per mole of carrier (37 groups/mole), and one with preparation II, contain- 
ing 32  groups/mole.  The same antigen was  used  to immunize and  challenge the animals. 
DNPS was similarly conjugated to RGG (28 groups/mole)  and  to BSA (36 groups/mole). 
O-Chlorobenzoyl chloride was conjugated to BGG according to the method of Benacerraf (8). 
Induction  of Tolera~e.--Newborn  guinea  pigs were divided in  three  groups:  Group I, 
20 newborn guinea pigs were injected twice i.p. with 4 mg of DNP-BGG, given on the day of 
birth and 1 wk later. Group II, 15 newborn guinea pigs were injected only once i.p. with 4 mg 
of DNP-BGG on the day of birth.  Group Ill,  15 control littermates were not injected with 
the antigen during the 1st wk of life. 
At 4  wk of age all animals,  control and  experimental, were immunized with 200 #g of 
DNP-BGG in complete Freund's  adjuvant  in all foot-pads.  At the  same  time 200  #g  of 
OCBC-BGG in complete adjuvant was injected subcutaneously. 
Eleven adult guinea pigs were pretreated with 2 i.p. injections of DNP-BGG given 7 days 
apart at either the same dose (group IV) as the newborn animals, or at a  dose adjusted to 
body weight so that they received the same amount per kilogram of body weight as the new- 
born guinea pigs (group V). All adult animals were similarly immuniz~ with 200 #g of DN-P- 
BGG in complete adjuvant in all foot-pads and  with 200  #g of OCBC-BGG in complete 
adjuvant subcutaneously. 
Skin  Tests.--The  animals injected neonatally,  as well as  control littermates,  were skin 
tested on the 14th day after the last injection of antigen. The animals were carefully shaved 
on their flank and 50 #g of the antigens (DNP-BGG, DNP-RGG, BGG, and OCBC-BGG) 
were injected intradermally in a volume of 0.1 ml of normal saline solution. The animals were 
observed at 2,  4,  6, and 24 hr and  the nature of the reactions, immediate or delayed, was 
differentiated and graded. Tmmediate reaction at 3 Jar was graded as follows: +, slight edema 
without hemorrhage; ++,  moderate to severe edema with or without slight hemorrhage; and 
+++,  severe edema with hemorrhage. Delayed reaction at 24 hr: +, induration 8 to 10 tam 
in diameter; ++,  induration 11 to 12 mm in diameter; and +++,  induration 13 to 15 mm 
in diameter. 
Arthus reactions appeared within 1 hr after challenge and were at their ma~mum intensi- 
ties at 2 to 3 hr. Delayed reactions appeared after 6 hr and reached their maximum intensi- 
ties at 1~ to 24 hr. These reactions were generally more severe than the immediate ones and 
consisted of erythema and induration,  occasionally with central necrosis.  The adult animals 
were skin tested on the 7th day after the imm,nizlng dose; the doses of antigen used to skin 
test were 10 and 50 #g. 
AntSbody DctermirJagam.--Animals of group I  were bled by intracardiac puncture at 4 wk 
of age prior to imm,_m;*atlon and all animals were bled by intracardiac puncture performed 
24 hr after each skin test; the following tests were used for the detection of antibodies. 
Passive hemagglut~nation: A modification of the micromethod of Heller et al. (9) was used. 
BGG, dinitrophenyl bovine gamma globulin; DNP-RGG, dinitrophenyl rabbit gamma globu- 
lin;  DNP-BSA,  dinitrophenyl  bovine  serum  albumin;  OCBC,  O-chlorobenzoyl  chloride; 
OCBC-BGG, O-chlorobenzoyl chloride bovine gamma globulin; BGG, bovine gamma globu- 
lin; BSA, bovine serum albunin; RGG, rabbit gamma globulin; HGG, human gamma globu- 
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If a preparation of DNP-BGG other than the one employed for the induction of tolerance 
was used, the number of groups per mole was in the same range as the original antigen, and 
in this instance a reference serum was also tested to insure that comparable titers were ob- 
tained with the 2 different preparations of DNP-BGG. In some experiments absorption stud- 
ies were carried out as follows: antibodies were assayed against DNP-BGG, DNP-RGG, and 
BGG in (a) native serum,  (b) serum absorbed with the whole original antigen, DNP-BGG, 
(c) serum absorbed in antigen excess with DNP-RGG and BGG, and (d) supernatant after 
precipitation of the antihapten antibody with DNP-RGG and then absorbing the resulting 
superuatant with the carrier protein BGG. The absorptions were done overnight at 4°C with 
0.2 nd of DNP-BGG (1.25 mg of protein/ml), for (b) or 0.2 nd of serum and 0.2 ml of DNP- 
RGG (1.25 mg of protein/m1)  and 0.2 ml BGG (1.25 mg of protein/rid) for (c). For (d), 0.5 
ml of serum and 0.1 ml containing the amount of DNP-RGG necessary to precipitate the 
total amount of anti-DNP antibody was incubated 1 hr at 37°C and then overnight at 4°C. 
The precipitate was spun down and removed,  and the resulting supernatant was then ab- 
sorbed with an equal amount of BGG (1.25 mg of protein/m1) as described above. These 
absorbed sera were tested in double diffusing agar plates against a rabbit serum anti-BGG 
and a guniea pig serum anti-DNP-BSA to insure that they were carried out in antigen excess. 
Passive hemolysis: The procedure described  by Kabat and Mayer (10) as modified by 
Bloch (11) has been used for this purpose.  In addition to the control test referred to (11), 
he,  t-inactivated guinea pig serum was used in order to compare the titer of the passive hemag- 
glutination with the titer of passive hemolysis. This test was done with the native serum and 
the superuatant after precipitation with DNP-RGG and absorption with BGG using tanned 
cells coated with DNP-BGG as the antigen. 
Passive cutaneous anaphylaxis: The method described by Ovary was used  (12). In the 
qualitative PCA a serum dilution of 1/100 and 250/~g of the antigen (DNP-BGG) were used. 
In the quantitative PCA for absorption studies seriM serum dilutions were done. Absorbed 
and nonabsorbed serum were used in the same animal: (a) native serum; (b) serum absorbed 
with DN'P-BGG (antigen used for immunization) ; and (c) serum was precipitated with DNP- 
RGG in slight antigen excess as described  in the paragraph of passive hemagglutination. 
After removal of precipitate the supematant was absorbed with BGG. Three animals were 
used for each antigen (DNP-BGG, DNP-RGG, and BGG). 
Agar gel di~uslon studies: Antibody activity against DNP-BGG, DNP-RGG, and BGG 
was also studied by agar gel double diffusion using the Petri dish method of Ouchterlony (13) 
RESULTS 
Delayed Hyperseruitidty.--It  was found that the majority of guinea pigs did 
not exhibit delayed hypersensitivity to an antigen  if  they had  been  injected 
twice in  the neonatal period with  this  antigen:  10  of  17  animals of group  I 
(injected twice neonatally with DNP-BGG) did not produce a positive delayed 
reaction to this antigen after subsequent immunization in complete adjuvant. 
On  the  other band,  all animals of this group had  a  positive ~kin reaction to 
OCBC-BGG,  the antigen given at the age of 4  wk  (Table I). All animals of 
group III (control littermates not injected neonatally) but immunized in com- 
plete adjuvant with DNP-BGG  and OCBC-BGG,  had a  positive skin test to 
DNP-BGG and all but one to OCBC-BGG (Table H). Injection of the antigen 
only once at birth did not result in the suppression of the 24 hr skin reaction at 6 
wk of age in a large proportion of animals: 8 out of 12 animals of group II pro- 
duced a  positive skin reaction to DNP-BGG while again all animals developed 588  DELAYED  HYPERSENSITIVITY 
a positive skin test to the second antigen OCBC-BGG. The result of the skin 
tests with BGG, i.e. the carrier protein, was similar to that of the skin tests with 
DNP-BGG. 
In contrast, administration of DNP-BGG to adult guinea pigs, either in the 
same amount as used in group I  or with a body weight adjusted dose, failed to 
affect the expression of delayed hypersensitivity to DNP-BGG after subsequent 
immunization in complete Freund's adjuvant. A summary of the results of all 
these experiments is given in Table HI. 
TABLE I 
24-H~ Skin Tests in Animals of Group I  at 6 Wk of Age 
Animal  No.  DNP-BGG  BGG  OCBC-BGG 
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*, negative;  -{-, 6 x  10 mm induration;  +-{-,  10 x  12 mm induration; +-{-+,  12 x  15 mm 
induration. 
In  order  to determine the  duration  of the  suppression  of delayed hyper- 
sensitivity to DNP-BGG, repeated skin tests were done in 10 animals in which 
delayed hypersensitivity was not observed at 6  wk of age.  Six animals  were 
skin tested at 2.5 months and 4 at 3.5 months. The results are listed in Table IV. 
Circulating  Antibodies.--The  sera of all  animals had  circulating antibodies 
to DNP-BGG, whether  or not  delayed hypersensitivity to  this  antigen was 
detectable. Antibodies were revealed in each animal by passive hemagglutina- 
tion and PCA.  In addition, most of the sera of animals of all groups gave a 
precipitin line in the Ouchterlony plates when tested with DNP-BGG (Table 
V). There was no relation between the titer of hemagglutination antibody and 
the presence or absence of delayed hypersensitivity or the type of treatment 
during the neonatal period (Table VI). YVES  BOREL~ MARTHE ~'AUCONNET~ AND PETER  A.  M'IESCHER 
Animal No. 
6-04 
6-07 
6-25 
6-14 
6-08 
6-02 
1-51 
1-59 
4-65 
1-52 
1-63 
1-54 
TABLE 11 
24-Hr Skin Tests in Animals of Group III at 6 Wk  f Age 
BGG  DNP-BGG 
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* See Table I. 
TABLE HI 
24-ttr Skin Tests in the Various Groups 
Neonatally injected animals  DNP-BGG  OCBC-BGG 
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Group I 
Group II 
Group HI (control littermat~) 
Adult animals 
Group IV 
Group V 
7/17 
8/12 
12/12 
6/6 
s/s 
17/17 
12/12 
12/12 
5/5 
* Not done. 
TABLE IV 
24-Hr Skin Test~ in Animals with a Negative Test at 6 Wk of Age 
Time of skin tests  DNP-BGG  OCBC-BGG 
m~t~ 
2.5  1/6  6/6 
3.5  2/4  4/4 
Most of the animals of the various groups when challenged with DNP-BGG 
expressed a mild Arthus reaction (from 1+ to 2+) to DNP-BGG (Table VII) 
which disappeared after 4 hr and did not interfere with the reading of delayed 
hypersensitivity. No difference in the intensity of the skin reaction was ob- 590  DELAYED  ~PERSENSITMTY 
TABLE  V 
Result of Precipitation Test in Agar Plates witk Sera against DNP-BGG 
Group I  Group II  Group III  Group IV -'k V 
14/17  8/12  12/12  II/II 
TABLE  VI 
Result o/Passive ttemaggIut~nation Test u~ith Sera o/Animals of  Groups I and III, 
g Wk after Immunizat4on with Freund's Adju~ant 
Group I  Group IlI 
Animals with  negative  Animals with  positive  Animals with  positive 
24-hr  skin  test  24-hr  skin  test  24-hr  skin  test* 
No.  Reciprocal  titer  No.  Reciprocal  titer 
6.03 
6-06 
6.10 
4-52 
1-27 
1-37 
1-46 
1-50 
3-75 
4-69 
1,024 
512 
1,024 
1,024 
512 
2,048 
1,024 
1,024 
1,024 
16,384 
Mean Titer  .......  1,260 
6.05  256 
4-67  2,O48 
1-56  2,048 
1-57  2,048 
4-72  1,024 
4-53  8,192 
6-92  16,384 
2,256 
6-04 
6-07 
6-25 
6-14 
6.08 
6.02 
1-51 
1-59 
4-65 
1-52 
1-63 
1-54 
No.  Reciprocal  titer 
128 
512 
4,096 
8,192 
1,024 
128 
4,096 
4,096 
2,048 
2,048 
2,048 
1,024 
1,367 
* No animal of group IlI had a negative 24 hr skin test. 
TABLE VII 
Result of Artkus  Type Sign Reactions Read at 3 lit 
Group I 
15/17 
Group II  Group III 
9/12  11/12 
Group IV + V 
11/11 
served in the various groups. Similar skin reactions were obtained with DNP- 
RGG, whereas BGG alone did not produce an Arthus phenomenon. 
Three newborn animals of group I  bled at 4 wk of age, prior to immuniza- 
tion with  DNP-BGG  in complete adjuvant,  formed antibody to  DNP-BGG 
(reciprocal titer  128,  512,  512)  as detected by passive hemagglutination. This YVES  BOREL~  MARTHE  FAUCONNET~  AND  PETER  A.  MIESCHER  591 
indicates that the antigen given in the neonatal period  did not  interfere with 
antibody formation. 
All animals had yt-antibodies since they were detectable by PCA (14). It was 
also investigated whether these animals formed complement binding, presuma- 
bly %-antibodies as detected by passive hemolysis. Two out of 10 sera studied 
in group I,  and  2 out of 6 sera studied in group III,  hemolysed the antigen- 
coated red cells in the presence of complement. 
Specificily of the Serologic Reactions.--The  specificity of the serologic reactions 
in  terms  of  carrier  protein,  hapten,  and  combined  hapten-carrier  protein 
specificity, were investigated by using different antigens in the passive hemag- 
glutination  test  and  by  absorption  studies.  The  results  of  passive  hemag- 
glutination tests are listed in Table VIII. 
TABLE VIII 
Result of Passive Hemagglutination Test for Detection of Serologic Specificity of 
Circulatin Antibodies 
Group I 
DNP-  BGG*  DNP- 
RGG*  BGG:~ 
Group II  Group III  i  Group IV +  V 
B Wd 
12/17  8/12  1/6  11/11  11/11  9/111 
* Nonabsorbed sera were used against DNP-RGG and BGG. 
Y; Sera were absorbed with DNP-RGG and BGG as outlined in Materials and Methods 
and used against the original antigen DNP-BGG. 
Hapten-specific antibodies were detected in all animals by the agglutination 
of red cells which were coated with the hapten bound to a carrier protein (RGG) 
unrelated to the one used for immunization.  (RGG was shown in preliminary 
studies not to react with anti-BGG sera.) 
Carrier protein-specific antibodies were detected in most of the animals by 
the use of BGG-coated cells. 
Combined  hapten-carrier  protein  specificity was  investigated  by  studying 
the  serologic  reactivity of  sera  which  have  been  absorbed  with  DNP-RGG 
(hapten bound to unrelated carrier protein) and with BGG (carrier protein) in 
antigen excess (see Fig. 1) or in two stages. (See Materials and Methods.) While 
these absorbed sera no longer agglutinated DNP-RGG- and BGG-coated cells, 
17 out of 40 of these sera still agglutinated red cells  coated with the original 
hapten-carrier protein  complex (DNP-BGG).  The  titer was  usually  2  steps 
less than the titer of the absorbed sera. This reactivity could only be removed bv 
absorption with the original antigen DNP-BGG. A typical example is given in 
Table  IX. 
In 2 sera which exhibited a combined hapten-carrier protein specificity at 2.5 592  DELAYED  IIYPIERSENSITIVITY 
months  of  age,  this  type of  specificity could not be detected  at  6  wk  of age. 
Although  the  antibody  titer  to  DNP-BGG  was  similar  at  the  two  different 
bleedings. 
Fro. 1.  Demonstration of antigen in the absorbed sera by agar diffusion technique.  The 
4 center wells contain 4 different  sera absorbed with DNP-RGG and BGG. The upper well 
contains rabbit anti-BGG serum, the lower well guinea pig anti-DNP-BSA serum. 
TABLE IX 
Passive Hemagglutination  Absorption  Study with the Serum of Animal 4-5!) of Group II with a 
Negative 24 Hr Skin  Test 
Treatment of serum 
Unabsorbed serum 
Serum absorbed with DNP-BGG 
Serum absorbed with DNP-RGG +  BGG 
Supernatant after precipitation with DNP-RGG and ab- 
sorption with BGG 
Reversed titer against red cells 
coated with: 
DNP-  DNP- 
BGG  RGG 
1024  32 
256  -- 
256  -- 
DNP- 
BSA 
32 
BGG 
128 
Out  of  10  sera  studied in  animals with  a  negative skin  test  to  DNP-BGG 
(groups  I  and  II),  3  animals'  sera  had  antibody  with  a  combined  hapten- 
carrier protein specificity. 
Six sera with a  combined hapten-carrier protein specificity as revealed in the 
passive hemagglutination absorption study were further  assayed by  PCA and 
passive  hemolysis.  (See  Table  X.) 
Native serum,  serum absorbed with  the complete original antigen,  and sera 
absorbed with  hapten  conjugated  to  RGG,  and  carrier protein as obtained in 
methods, were assayed against DNP-BGG, DNP-RGG, and BGG. An example 
showing this combined hapten-carrier protein specificity as detected by PCA is YVES BOP.EL, MARTIIE FAUCONNET, AND PETER A. MIESCHER  593 
given in Table XI. By PCA and passive  hemolysis all  6 sera had this com- 
bined hapten-carrier protein specificity  left after absorption  of hapten  and 
carrier protein specific antibodies (Table X). It might be coincidental that no 
serum exhibited this combined specificity in both methods detecting different 
classes of antibody. 
TABLE X 
PCA and Passive Hemdys~s Assays witk 6 Sera ExMb~'ng a Combi~w~  DNP-BGG  Specificity 
in the Passive Hemaggbutination Test 
The sera have been exhaustively absorbed with DNP-RGG and BGG. 
Animal No.. 
PCA assay  .... 
Passive hemolysis  .... 
Group I  Group II  Group IV + V 
4-69  6-92 
+  - 
-  + 
1-60  1-70 
+  - 
-  + 
1-24  6-83 
+  + 
TABLE XI 
Passive Cutaneou~ Anapkylaxis Absorption Study wltk the Serum of Animal 144  of Group IV 
with a Positive 24  hr Skin  Test 
Treatment of serum 
Unabsorbed serum 
Serum absorbed with DNP-BGG 
Superuatant after precipitation with DNP-RGG and absorption 
with BGG 
Reversed titer against: 
DNP-  DNP-  BGG  BGG  RGG 
1600  800  200 
400 
DISCUSSION 
The  experiments  reported  here  have shown that  admiIlistration  of  DNP-BGG 
to newborn guinea-pigs  resulted  in  the suppression of delayed hypersensitivity 
to this  antigen in more than half  of the animals.  This suppression was specific 
and long lasting.  In contrast,  all  animals formed circulating  antibodies,  whether 
or not delayed hypersensitivity  was present. Delayed hypersensitivity  was 
suppressed in animals treated with  the  antigen  in the neonatal period only and 
not in adult guinea pigs  pretreated  with the same amount of antigen per kg of 
body  weight  (117  nag  of  DNP-BGG/kg).  Whether  suppression  of  delayed 
hypersensitivity, as measured by a  negative 24 hr skin test, was complete or 
incomplete cannot be determined. However, it is relevant to note that antibody 
titers,  as  detected  by  passive  hemagglutination,  were  similar  in  animals  in 594  DELAYED  HYPERSENSITIVITY 
which delayed hypersensitivity has been suppressed and in animals  exhibiting 
delayed hypersensitivity. These results indicate that  a  state of tolerance has 
been induced in terms of delayed hypersensitivity only without affecting  anti- 
body formation to the same antigen. 
Suppression  of delayed hypersensitivity only without suppression  of anti- 
body formation to the same antigen may be due to differences in antigenic de- 
terminants  involved in these two immune phenomena,  or alternatively,  may 
indicate that immunologic  tolerance in terms of delayed hypersensitivity was 
induced  to  one  antigenic  determinant,  without  concomitant  suppression  of 
antibody formation to the same antigenic determinant.  In the first case,  one 
would deal with the induction  of tolerance to only part of the antigenic de- 
terminants,  (those responsible for the 24 hr skin test), and not to others, (those 
responsible for the serologic tests). Such an immunologic phenomenon would be 
analogous to what has been referred to as "split tolerance" in transplantation 
immunity (15). In the second case, delayed hypersensitivity and antibody for- 
marion directed to the same antigenic determinant would have been dissociated 
by the induction of immunologic  tolerance. 
In order to attack this problem the specificity of delayed hypersensitivity 
versus the specificity of antibody formation has been further investigated. In 
all control animals  the 24 hr skin test was positive with the original  antigen 
DN-P-BGG and in most of the animals with the carrier protein, BGG, alone. It 
is interesting to note that in most experimental animals in which delayed hyper- 
sensitivity to DNP-BGG was suppressed,  this skin reaction was also suppressed 
to  the carrier  protein  alone.  The  suppression  of delayed hypersensitivity to 
DNP-BGG and BGG was specific, since all control and experimental animals 
were able to exhibit delayed hypersensitivity to an unrelated antigen OCBC- 
BGG given together with DNP-BGG in complete adjuvant. The results of the 
serologic studies in the sera of animals of all groups have shown antibodies with 
three different specificities:  the hapten,  the carrier  protein,  and the combined 
hapten-carrier protein specificity. Antibody with a combined hapten-carrier pro- 
tein specificity, i.e. with a specificity similar to that of delayed hypersensitivity 
to a hapten-carrier protein complex  (16), has previously been found in guinea 
pigs at the onset of the primary immune response only (17). In the present study 
such antibodies were found also later in the course of immunization.  For the 
question discussed  above, it is particularly relevant to note, that such a com- 
bined hapten-carrier  protein  specificity  to  DNP-BGG was found in animals 
which did not exhibit delayed hypersensitivity to DNP-BGG. Equally impor- 
tant for this question is the fact that antibody activity against the carrier protein, 
BGG, alone was present in 8 of 10 animals  with a negative 24 hr skin reaction 
to BGG. Thus, suppression  of delayed hypersensitivity to the original  antigen 
(DNP-BGG) as well as to the carrier protein (BGG) was found in animals  ex- 
hibiting antibody activitv with both types of specificifies, the combined hapten- YVES  BOREL,  M.ARTHE ~AUCONN'ET, AND PETER  A.  MIESCHER  595 
cartier and the carrier specificity.  From these results, it appears unlikely that 
suppression of delayed hypersensitivity was due to induction of tolerance to 
only part of the antigenic determinants; theyrather suggest that delayed hyper- 
sensitivity and antibody formation to similar antigenic determinants have been 
dissociated by the induction of immunologic  tolerance. 
Reports by others have previously shown that both delayed hypersensitivity 
and antibody formation were suppressed by administration of antigens to new- 
born animals  (18-20).  Turk  and  Humphrey  (18)  found that  guinea pigs in- 
jected prenatally and neonatally with BSA and HGG failed to elaborate circu- 
lating  antibody and delayed hypersensitivity responses  when challenged  with 
these antigens later in life. However, in one group of pretreated animals,  im- 
munization with HGG in Freund's adjuvant resulted in antibody production 
in some of the animals while all animals had a negative 24 hr skin test to HGG. 
This group of animals may reflect a dissociation  of the immune responses simi- 
lar to the one observed in the present experiment, although the specificities of 
delayed  hypersensitivity  and  antibody  formation  were  not  further  investi- 
gated. 
Administration  of antigens to adult guinea pigs prior to immunization  with 
Freund's  adjuvant resulted in most of the experiments in the suppression of 
both delayed hypersensitivity and  antibody formation  (21-24).  However, in 
some of these studies delayed hypersensitivity has been preferentially affected 
(22, 23). Thus Chase and Battisto found that prolonged feeding of adult guinea 
pigs with picryl chloride  (PC1) resulted in tolerance to topical application  of 
the hapten;  also no antibodies to the hapten  were formed in  these animals. 
However, when guinea pigs were immunized with picryl chloride conjugated in 
vitro to a heterologous protein carrier in Freund's adjuvant, only antibodies to 
the PC1 group were formed, but no contact sensitivity to cutaneous application 
of PC1 could be detected.  It  should be noted  that  the specificity of contact 
sensitivity is known to be directed to a  combined hapten  autologous carrier 
skin protein while  the specificity of the antibody response is directed to the 
hapten  or  the  hapten-carrier  protein  complex  used  for  immunization  (25). 
Thus two different antigenic determinants were involved in contact  sensitivity 
and antibody formation which makes the interpretation of selective suppression 
of one of the two immune responses difficult. 
Experiments reported by Boyden (26) and more recently by Dvorak et al. 
(24) and Asherson et al. (27) appear to be closely related to the present study. 
Boyden has found that administration of tuberculoprotein to adult guinea pigs, 
prior to immunization with BGG, resulted in the diminution of delayed but not 
immediate skin sensitivity. Dvorak et al.  reported that  treatment  with anti- 
gens,  administered  either  prior  to  or  simultaneously  with  immunization  in 
complete adjuvant, resulted in the suppression  of delayed hypersensitivity and 
complement-fixing  antibody. However, ~,rantibodies were less affected. 596  DELAYED  HYPERSENSITMTY 
Asherson  selectively suppressed delayed hypersensitivity without abolishing 
antibody formation by administration  of various  antigens  before or  shortly 
after immunization with the same antigen in complete adjuvant. In some of the 
experimental animals  the ~yz-antibodies were preferentially suppressed.  In the 
present series of experiments,  no qualitative difference in antibody formation 
was found in control and experimental animals.  However, only very few guinea 
pigs in either group exhibited complement-fixing  (~'2, ~)  antibody activity. 
It is not possible from the present data to determine the exact mechanism 
underlying the preferential suppression  of delayed hypersensitivity. However, 
the finding  that this suppression  could be achieved in animals  injected in the 
neonatal period, but not in adult animals,  suggests a mechanism similar to that 
operating  in  the induction  of immunologic  tolerance.  The mere  observation 
that delayed hypersensitivity can be dissociated from antibody formation by 
selective induction of immunologic  unresponsiveness  provides further evidence 
that these two immunologic processes may be basically different. 
sum~tar¢ 
Administration of DNP-BGG to newborn guinea pigs resulted, in more than 
half of the animals,  in the specific suppression  of delayed hypersensitivity to 
DNP-BGG and BGG, as shown after immunization with DNP-BGG in com- 
plete Freund's adjuvant. 
In contrast, all animals formed antibodies to DNP-BGG, whether or not de- 
layed hypersensitivity to this antigen was present.  No difference in antibody 
titers was found between pretreated and control animals.  All animals had anti- 
bodies reacting specifically to the hapten DNP, and most of them to the carrier 
protein B GG, whether or not delayed hypersensitivity to the carrier protein was 
present. Furthermore, some animals  with and without positive 24 hr skin test 
to DNP-BGG had antibodies with a combined hapten-carrier protein specificity 
to this antigen,  i.e., a specificity which is similar to that of delayed hypersensi- 
tivity. Thus, delayed hypersensitivity and antibody formation to similar  anti- 
genie  determinant  were differently affected by injection of antigen in the neo- 
natal period. 
The finding  that delayed hypersensitivity and antibody formation could be 
dissociated by the induction of immunologic  tolerance supports the assumption 
that  delayed hypersensitivity  and  antibody formation  are different immune 
processes which are not necessarily linked together. 
We are indebted  to  Dr.  J.  David and  Dr.  R.  Schwartz for  their critical  review  of this 
paper. 
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